GEORGE CHOLANKERIL to Nutrition Surveys
This is a "connection" page, showing publications GEORGE CHOLANKERIL has written about Nutrition Surveys.
Connection Strength
1.735
-
The prevalence and predictors of metabolic dysfunction-associated steatotic liver disease and fibrosis/cirrhosis among adolescents/young adults. J Pediatr Gastroenterol Nutr. 2024 07; 79(1):110-118.
Score: 0.729
-
Steatotic liver disease-associated all-cause/cause-specific mortality in the United States. Aliment Pharmacol Ther. 2024 07; 60(1):33-42.
Score: 0.182
-
Association of High-Sensitivity Troponins in Metabolic Dysfunction-Associated Steatotic Liver Disease With All-Cause and Cause-Specific Mortality. Aliment Pharmacol Ther. 2025 Jun; 61(11):1785-1793.
Score: 0.049
-
Current Burden of Lean Metabolic Dysfunction-Associated Steatotic Liver Disease Among US Adults, 2017-2023. Aliment Pharmacol Ther. 2025 Mar; 61(5):891-894.
Score: 0.048
-
Current burden of steatotic liver disease and fibrosis among adults in the United States, 2017-2023. Clin Mol Hepatol. 2025 Apr; 31(2):382-393.
Score: 0.048
-
Estimated pulse wave velocity in metabolic dysfunction-associated steatotic liver disease and all-cause/cause-specific mortality. J Gastroenterol Hepatol. 2024 Sep; 39(9):1950-1956.
Score: 0.046
-
Association between food insecurity and metabolic dysfunction-associated steatotic liver disease/significant fibrosis measured by fibroscan. Eur J Nutr. 2024 Apr; 63(3):995-1001.
Score: 0.045
-
Endogenous sex hormones and nonalcoholic fatty liver disease in US adults. Liver Int. 2024 02; 44(2):460-471.
Score: 0.044
-
Depression in nonalcoholic fatty liver disease and all-cause/cause-specific mortality. Eur J Clin Invest. 2024 Jan; 54(1):e14087.
Score: 0.044
-
Association between depression and metabolic dysfunction-associated fatty liver disease/significant fibrosis. J Affect Disord. 2023 05 15; 329:184-191.
Score: 0.042
-
Gallstone Disease and Its Association With Nonalcoholic Fatty Liver Disease, All-Cause and Cause-Specific Mortality. Clin Gastroenterol Hepatol. 2023 04; 21(4):940-948.e2.
Score: 0.040
-
Trends in the Prevalence of Hepatitis C Virus Infection based on the Insurance Status in the United States from 2013 to 2018. Liver Int. 2022 02; 42(2):340-349.
Score: 0.039
-
Physical Activity Is Associated With Nonalcoholic Fatty Liver Disease and Significant Fibrosis Measured by FibroScan. Clin Gastroenterol Hepatol. 2022 06; 20(6):e1438-e1455.
Score: 0.038
-
Sarcopenia in nonalcoholic fatty liver disease and all-cause and cause-specific mortality in the United States. Liver Int. 2021 08; 41(8):1832-1840.
Score: 0.037
-
Prevalence of Nonalcoholic Fatty Liver Disease and Hepatic Fibrosis Among US Adults with Prediabetes and Diabetes, NHANES 2017-2018. J Gen Intern Med. 2022 01; 37(1):261-263.
Score: 0.037
-
Inadequate Physical Activity and Sedentary Behavior Are Independent Predictors of Nonalcoholic Fatty Liver Disease. Hepatology. 2020 11; 72(5):1556-1568.
Score: 0.036
-
Low Thyroid Function in Nonalcoholic Fatty Liver Disease Is an Independent Predictor of All-Cause and Cardiovascular Mortality. Am J Gastroenterol. 2020 09; 115(9):1496-1504.
Score: 0.035
-
Physical Activity, Measured Objectively, Is Associated With Lower Mortality in Patients With Nonalcoholic Fatty Liver Disease. Clin Gastroenterol Hepatol. 2021 06; 19(6):1240-1247.e5.
Score: 0.035
-
Diet quality and its association with nonalcoholic fatty liver disease and all-cause and cause-specific mortality. Liver Int. 2020 04; 40(4):815-824.
Score: 0.034
-
Depression is associated with non-alcoholic fatty liver disease among adults in the United States. Aliment Pharmacol Ther. 2019 09; 50(5):590-598.
Score: 0.033
-
Elevated urinary bisphenol A levels are associated with non-alcoholic fatty liver disease among adults in the United States. Liver Int. 2019 07; 39(7):1335-1342.
Score: 0.032
-
Race/ethnicity-based temporal changes in prevalence of NAFLD-related advanced fibrosis in the United States, 2005-2016. Hepatol Int. 2019 Mar; 13(2):205-213.
Score: 0.032
-
Low-Normal Thyroid Function Is Associated With Advanced Fibrosis Among Adults in the United States. Clin Gastroenterol Hepatol. 2019 10; 17(11):2379-2381.
Score: 0.031